Molecule Structure

Scientific Name

Flutamide

Description of the Drug

Flutamide is an antiandrogen used for locally confined stage B2-C and D-2 metastatic prostate carcinoma.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00499

Brand Name(s)

Chimax, Drogenil, Eulexin, Flutamide

Company Owner(s)

Mylan Pharmaceuticals Inc, Actavis Laboratories Fl Inc, Schering Corp Sub Schering Plough Corp, Waylis Therapeutics Llc, Yaopharma Co Ltd, Cipla Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Androgen Receptor SINGLE PROTEIN ANTAGONIST CHEMBL1871

Unichem Links

Atlas flutamide
SureChEMBL SCHEMBL3934
PharmGKB PA449685
Human Metabolome Database HMDB0014642
WDI FLUTAMIDE
DrugBank DB00499
PubChem: Thomson Pharma 15222063
PubChem 3397
Mcule MCULE-7498839065
LINCS LSM-2621
BindingDB 50131270
EPA CompTox Dashboard DTXSID7032004
DrugCentral 1223
Brenda 37969
ChemicalBook CB2468110
Guide to Pharmacology 6943
GSRS ceb90449-01d7-485e-b6b3-ee173f370818
rxnorm FLUTAMIDE
PubChem: Drugs of the Future 12013361
KEGG Ligand C07653
ChEBI 5132
NIH Clinical Collection SAM002264612
ZINC ZINC000003812944